Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations-Reference-Cited by-同舟云学术

Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations

Published:2012-02 Issue:2 Volume:28 Page:156-164
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Garrido Carolina¹,de Mendoza Carmen¹,Álvarez Elena¹,García Federico²,Morello Judit¹,Garcia Silvia³,Ribera Esteban⁴,Rodríguez-Novoa Sonia¹,Gutierrez Felix⁵,Soriano, on behalf of the SinRES Te Vincent¹

Affiliation:

1. Infectious Diseases Department, Hospital Carlos III, Madrid, Spain.

2. Microbiology Department, Hospital Clínico Universitario San Cecilio, Granada, Spain.

3. Microbiology Department, Hospital La Paz, Madrid, Spain.

4. Hospital Vall d'Hebrón, Barcelona, Spain.

5. Hospital General Universitario, Elche, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2010.0370

Reference38 articles.

1. Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States

2. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

3. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

2. Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy;International Journal of STD & AIDS;2022-12-18

3. Impact of genotypic diversity on selection of subtype-specific drug resistance profiles during raltegravir-based therapy in individuals infected with B and BF recombinant HIV-1 strains;Journal of Antimicrobial Chemotherapy;2020-03-03

4. Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review;Therapeutic Drug Monitoring;2020-02

5. Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps;Clinical Pharmacokinetics;2018-06-19